Trichloroethylene and Parkinson's disease: Dissolving the puzzle

Expert Review of Neurotherapeutics

Volumn 10, Issue 6, 2010, Pages 835-837

  Goldman, Samuel M ^a  

^a PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROETHYLENE;

EDITORIAL; ENVIRONMENTAL EXPOSURE; GENETIC ANALYSIS; INDUSTRIAL HYGIENE; PARKINSON DISEASE; PARKINSONISM; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ENVIRONMENTAL EXPOSURE; HUMANS; PARKINSON DISEASE; TRICHLOROETHYLENE;

EID: 77953218414     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.61     Document Type: Editorial

References (35)

1. Thaler A, Ash E, Gan-Or Z, Orr-Urtreger A, Giladi N. The LRRK2 G2019S mutation as the cause of Parkinson's disease in Ashkenazi Jews. J. Neural Transm. 116(11), 1473-1482 (2009).
2. Latourelle JC, Sun M, Lew MF et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 6, 32 (2008).
3. Clark LN, Wang Y, Karlins E et al. Frequency of LRRK2 mutations in earlyand late-onset Parkinson disease. Neurology 67(10), 1786-1791 (2006).
4. Ozelius LJ, Senthil G, Saunders-Pullman R et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N. Engl. J. Med. 354(4), 424-425 (2006).
5. Tanner CM, Ottman R, Goldman SM et al. Parkinson disease in twins. An etiologic study. JAMA 281(4), 341-346 (1999). (Pubitemid 29061038)
6. Wirdefeldt K, Gatz M, Schalling M, Pedersen NL. No evidence for heritability of Parkinson disease in Swedish twins. Neurology 63(2), 305-311 (2004). (Pubitemid 38971131)
7. Guttman M, Slaughter PM, Theriault ME, DeBoer DP, Naylor CD. Parkinsonism in Ontario: increased mortality compared with controls in a large cohort study. Neurology 57(12), 2278-2282 (2001).
8. Wermuth L, Bech S, Petersen MS et al. Prevalence and incidence of Parkinson's disease in The Faroe Islands. Acta Neurol. Scand. 118(2), 126-131 (2008).
9. Wang YS, Shi YM, Wu ZY, He YX, Zhang BZ. Parkinson's disease in China. Coordinational Group of Neuroepidemiology, PLA. Chin. Med. J. 104(11), 960-964 (1991).
10. Zhang ZX, Roman GC, Hong Z et al. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 365(9459), 595-597 (2005).
11. Bronstein J, Carvey P, Chen H et al. Meeting report: consensus statement- Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007. Environ. Health Perspect. 117(1), 117-121 (2009).
12. Guggenheim MA, Couch JR, Weinberg W. Motor dysfunction as a permanent complication of methanol ingestion. Presentation of a case with a beneficial response to levodopa treatment. Arch. Neurol. 24(6), 550-554 (1971).
13. Pezzoli G, Barbieri S, Ferrante C, Zecchinelli A, Foà V. Parkinsonism due to n-hexane exposure. Lancet. 2(8667), 874 (1989).
14. McCrank E, Rabheru K. Four cases of progressive supranuclear palsy in patients exposed to organic solvents. Can. J. Psychiatry. 34(9), 934-936 (1989).
15. Tetrud JW, Langston JW, Irwin I, Snow B. Parkinsonism caused by petroleum waste ingestion. Neurology 44(6), 1051-1054 (1994).
16. Uitti RJ, Snow BJ, Shinotoh H et al. Parkinsonism induced by solvent abuse. Ann. Neurol. 35(5), 616-619 (1994).
17. Hertzman C, Wiens M, Snow B, Kelly S, Calne D. A case-control study of Parkinson's disease in a horticultural region of British Columbia. Mov. Disord. 9(1), 69-75 (1994).
18. Pals P, Van Everbroeck B, Grubben B et al. Case-control study of environmental risk factors for Parkinson's disease in Belgium. Eur. J. Epidemiol. 18(12), 1133-1142 (2003).
19. McDonnell L, Maginnis C, Lewis S et al. Occupational exposure to solvents and metals and Parkinson's disease. Neurology 61(5), 716-717 (2003).
20. Tanner CM, Ross GW, Jewell SA et al. Occupation and risk of parkinsonism: a multicenter case-control study. Arch. Neurol. 66(9), 1106-1113 (2009).
21. Dick S, Semple S, Dick F, Seaton A. Occupational titles as risk factors for Parkinson's disease. Occup. Med. (Lond.) 57(1), 50-56 (2007).
22. Seidler A, Hellenbrand W, Robra BP et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology 46(5), 1275-1284 (1996).
23. Firestone JA, Lundin JI, Powers KM et al. Occupational factors and risk of Parkinson's disease: a population-based case-control study. Am. J. Ind. Med. 53(3), 217-223 (2010).
24. Lam HR, Ostergaard G, Ladefoged O. Three weeks' and six months' exposure to aromatic white spirit affect synaptosomal neurochemistry in rats. Toxicol. Lett. 80(1-3), 39-48 (1995).
25. Mattia CJ, Ali SF, Bondy SC. Tolueneinduced oxidative stress in several brain regions and other organs. Mol. Chem. Neuropathol. 18(3), 313-328 (1993).
26. Gash DM, Rutland K, Hudson NL et al. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann. Neurol. 63(2), 184-192 (2008).
27. Guehl D, Bezard E, Dovero S, Boraud T, Bioulac B, Gross C. Trichloroethylene and parkinsonism: a human and experimental observation. Eur. J. Neurol. 6(5), 609-611 (1999).
28. Kochen W, Kohlmuller D, De Biasi P, Ramsay R. The endogeneous formation of highly chlorinated tetrahydro-b-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Adv. Exp. Med. Biol. 527, 253-263 (2003).
29. World Health Organization. International Agency for Research on Cancer (IARC): Monographs on the Evaluation of Carcinogenic Risks to Humans (Volume 63). WHO, Geneva, Switzerland (1997).
30. Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological Profile for Trichloroethylene. United States Department of Health and Human Services, Atlanta, GA, USA (1997).
31. Wu C, Schaum J. Exposure assessment of trichloroethylene. Environ. Health Perspect. 108(Suppl. 2), 359-363 (2000).
32. Goldman SM, Tanner CM, Meng C et al. Parkinson's disease risk is increased in discordant twins exposed to specific solvents. Presented at: The American Academy of Neurology Annual Meeting. Toronto, ON, Canada, 10-17 April 2010.
33. Liu M, Choi DY, Hunter RL et al. Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats. J. Neurochem. 112(3), 773-783 (2010).
34. Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24(2), 197-211 (2003).
35. Di Monte DA. Mitochondrial DNA and Parkinson's disease. Neurology 41(5 Suppl. 2), 38-42 (1991).